The institute is a faculty-led initiative developed over the past several years. We set out to exploit synergies between the curiosity-based investigation of fundamental biological mechanisms and the early-stage identification and validation of molecular therapeutic targets. Our goal is to leverage the strengths of our intensive and collaborative research environment.
The institute was launched in May 2016 as an NIH Center of Biomedical Research Excellence, with a $12.5M award from the NIH and strong institutional support from Dartmouth College. In addition to funding for four junior faculty research projects, BioMT also supports advanced scientific resources for cross-campus use, faculty and student mentoring, an annual symposium, and a weekly seminar series.
Funding is provided by award P20-GM113132 from the IDeA program of the NIH National Institute of General Medical Sciences, Dartmouth College, the Geisel School of Medicine, the Thayer School of Engineering, and the Norris Cotton Cancer Center.
We also work closely with the Digital Arts, Leadership & Innovation (DALI) Lab, the Dartmouth Entrepreneurial Network (DEN), other IDeA Programs at Dartmouth (immunology, Lung Biology, Molecular Epidemiology, and Quantitative Biology COBRE programs and NH-INBRE) and across New England (Vermont Genetics Network and Maine INBRE).